fda drug shortages semaglutide injection shortage resolved 2025 Compound versions of GLP-1 drugs for weight loss halted by FDA: Ozempic and Wegovy drug

The American Diabetes Association (ADA) guidelines recognize GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who require additional glucose-lowering therapy beyond metformin, particularly those with established cardiovascular disease or chronic kidney disease, with preference given to agents with proven cardiovascular benefit

Avoid medications that are proton pump inhibitors

Over-the-Counter and Prescription Options to Manage Tirzepatide-Related Nausea Ginger supplements (5001000 mg daily in divided doses) and dramamine-class antihistamines like meclizine reduce nausea signaling without interfering with tirzepatide's mechanism

Dehydration can worsen if you are also experiencing certain side effects of a GLP-1 medication, such as nausea or vomiting

Educational Resources for the Muaythai Community To help our athletes, officials, and National Federations better understand these changes, WADA has provided a suite of educational resources, including: A checklist for implementing the revised List